酶促伤口清创市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按类型(慢性伤口、急性伤口)、产品、最终用户和地理位置进行细分。

市场快照

Enzymatic Wound Debridement Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.3 %
Enzymatic Wound Debridement Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

酶促伤口清创市场预计在预测期内以近 5.3% 的复合年增长率增长。推动市场增长的主要因素是糖尿病、癌症等慢性病发病率的增加,其他自身免疫性疾病是推动增长的主要因素之一。

根据国际糖尿病联盟的数据,2019 年大约有 4.63 亿成年人患有糖尿病,到 2045 年,这一数字将增加到 7 亿,大约 3.74 亿人患 2 型糖尿病的风险增加。糖尿病患者病例的增加表明糖尿病足溃疡等慢性伤口的数量不断增加,这正在促进所研究市场的增长。此外,政府为开发该领域的医疗基础设施而对研发项目的投资不断增加,正在推动市场增长。然而,严格的监管政策是市场增长的主要障碍。

报告范围

根据报告的范围,清创是从伤口中去除感染组织直到暴露健康组织的过程。酶清创是在伤口表面使用外源酶的过程,因此坏死组织的降解可以发生,而不会对活的肉芽组织产生任何负面影响。此报告按类型、产品、最终用户和地理位置细分。

By Type
Chronic Wounds
Acute Wounds
By Product
Collagenase Product
Papain Product
Others
By End-User
Hospitals
Homecare
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

基于胶原酶的酶促伤口清创产品有望见证快速增长

基于胶原酶的酶促伤口清创产品主要用于愈合手术伤口。大多数癌症手术后的手术伤口相对较大且较深,会产生需要定期监督的渗出液。因此,正确使用这些产品有助于处理大伤口,从而大大降低感染风险。因此,慢性病发病率的上升预计将增加对酶促伤口清创产品的需求,从而推动预测期内的市场增长。

此外,预计世界各地越来越多的事故,如道路事故、烧伤和创伤也将推动增长。根据世界卫生组织的数据,每年有 135 万人死于道路交通事故。因此,预计事故数量的增加将推动该细分市场的增长。

Enzymatic Wound Debridement Market Trends

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个市场。市场增长是由于关键参与者的存在、该地区慢性病和事故的高发率以及已建立的医疗基础设施等因素。根据美国创伤外科协会的数据,2017 年,全球约有 120 万人死亡,每年约有 3,242 人死于道路事故。此外,有益的政府举措和研究合作伙伴数量的增加是预计增加市场增长的一些驱动因素。

Enzymatic Wound Debridement Market Growth

竞争格局

酶伤口清创市场竞争中等,由几个主要参与者组成。目前市场上的一些公司是 B. Braun Melsungen AG、ConvaTec Inc.、Smith & Nephew、Integra LifeSciences Corporation、Mölnlycke Health Care AB、Healthpoint, Ltd、MediWound。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Chronic Wounds

      2. 4.2.2 Increasing Number of Accidents

      3. 4.2.3 Increasing Technologically Advanced Products

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent regulatory policies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Chronic Wounds

      2. 5.1.2 Acute Wounds

    2. 5.2 By Product

      1. 5.2.1 Collagenase Product

      2. 5.2.2 Papain Product

      3. 5.2.3 Others

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Homecare

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 B. Braun Melsungen AG

      2. 6.1.2 ConvaTec Inc.

      3. 6.1.3 Smith & Nephew

      4. 6.1.4 Integra LifeSciences Corporation

      5. 6.1.5 Molnlycke Health Care AB

      6. 6.1.6 Healthpoint, Ltd

      7. 6.1.7 MediWound

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Enzymatic Wound Debridement Market market is studied from 2018 - 2026.

The Enzymatic Wound Debridement Market is growing at a CAGR of 5.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

B. Braun Melsungen AG, ConvaTec Inc., Smith & Nephew, Integra LifeSciences Corporation, Mölnlycke Health Care AB are the major companies operating in Enzymatic Wound Debridement Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!